Douglas Flora: How AI will shape Oncology Care
Douglas Flora posted on LinkedIn:
“Artificial intelligence (AI) is opening up new possibilities in oncology, from early detection to personalized treatment plans. But what’s most exciting is how AI can empower us to provide even more compassionate, precise care.
I hope I’ve captured this excitement in my most recent ACCC Blog below.
At ACCC, we’re focused on helping oncology teams integrate these tools into their practice, ensuring that AI enhances—not replaces—the human touch. This is an opportunity for all of us to learn, adapt, and shape the future of cancer care together.”
Read Further.
Source: Douglas Flora/LinkedIn
Douglas Flora is the Executive Medical Director of Oncology Services at St. Elizabeth Healthcare, overseeing clinical operations, strategic planning, and the expansion of cancer programs. He is also the co-founder of the Center for Precision Medicine; Genomic Health.
As the Editor-in-Chief of ‘AI in Precision Oncology,’ the first peer-reviewed academic journal dedicated to this field, he plays a pivotal role in advancing research. He is also an active board member of the American Cancer Society and ACCC, where he contributes to advocacy, education, and innovation within the cancer community.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023